Company intelligence

Khartis Therapeutics

Biotech

Suggest a correction

Recent changes

Aug 13, 2026Aug 13, 2026Raised $50M Series B Axios
Aug 13, 2026Aug 13, 2026New investor: Foresite Capital Axios
Aug 13, 2026Aug 13, 2026New investor: Nextech Invest Axios

Funding History

1 event · sources dated per row

Date	Event	Amount	Valuation	Investors	Source
Aug 13, 2026	Series B	$50M	—	Foresite Capital Nextech InvestForge Life Science PartnersLilly Asia Ventures	Pulse story

Investors

Foresite Capital Nextech Invest

Latest Pulse

Aug 13, 2026Khartis Emerges From Stealth With $95M for a Thyroid PillKhartis Therapeutics emerged from stealth with $95 million in total funding, including a new $50 million Series B, to develop an oral alternative to injectable treatments for thyroid eye disease.→

Coverage Timeline

newest first

Aug 13, 2026FUNDINGKhartis Emerges From Stealth With $95M for a Thyroid Pill$50M Series B→

All Coverage

FUNDING· Aug 13, 2026

Khartis Emerges From Stealth With $95M for a Thyroid Pill

Illustration for: Khartis Emerges From Stealth With $95M for a Thyroid Pill

FUNDING$50M Series B

Khartis Emerges From Stealth With $95M for a Thyroid Pill

Khartis Therapeutics emerged from stealth with $95 million in total funding, including a new $50 million Series B, to develop an oral alternative to injectable treatments for thyroid eye disease.

Aug 13, 2026DEEP DIVE

Related Companies

Same sector

Attovia Therapeutics Apnimed Braveheart Bio Latigo Biotherapeutics Scribe Therapeutics

Sources & methodologyshow

Where these figures come from

Axiosmajor outlet1 fact

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction